364 related articles for article (PubMed ID: 28946474)
1. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
Kumar S; Randhawa JK
Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
[TBL] [Abstract][Full Text] [Related]
3. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
Hassani Najafabadi A; Abdouss M; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
[TBL] [Abstract][Full Text] [Related]
6. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction.
Hosny KM; Aljaeid BM
Expert Opin Drug Deliv; 2014 Jul; 11(7):1015-22. PubMed ID: 24746063
[TBL] [Abstract][Full Text] [Related]
9. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
10. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
[TBL] [Abstract][Full Text] [Related]
13. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
14. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
15. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
16. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Biomed Nanotechnol; 2010 Dec; 6(6):634-40. PubMed ID: 21361127
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticle: A potent vehicle of the kaempferol for brain delivery through the blood-brain barrier in the focal cerebral ischemic rat.
Ghosh A; Khanam N; Nath D
Chem Biol Interact; 2024 Jul; 397():111084. PubMed ID: 38823537
[TBL] [Abstract][Full Text] [Related]
18. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
[TBL] [Abstract][Full Text] [Related]
19. Acoustic Cavitation-Assisted Formulation of Solid Lipid Nanoparticles using Different Stabilizers.
Kumar R; Singh A; Garg N
ACS Omega; 2019 Aug; 4(8):13360-13370. PubMed ID: 31460464
[TBL] [Abstract][Full Text] [Related]
20. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]